POTENTIALLY RESECTABLE HEPATOCELLULAR CARCINOMA

Clinical trials for POTENTIALLY RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new POTENTIALLY RESECTABLE HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for POTENTIALLY RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New cocktail aims to make liver cancer operable

Disease control Terminated

This study tests a combination of chemotherapy, immunotherapy, and a targeted drug given directly into the liver's blood supply to shrink tumors in people with liver cancer that may be removable with surgery. The goal is to see if this approach can make surgery more effective and…

Matched conditions: POTENTIALLY RESECTABLE HEPATOCELLULAR CARCINOMA

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jun 15, 2026 19:07 UTC

POTENTIALLY RESECTABLE HEPATOCELLULAR CARCINOMA

Get alerted when new POTENTIALLY RESECTABLE HEPATOCELLULAR CARCINOMA trials appear

New cocktail aims to make liver cancer operable